These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3012165)

  • 1. Cardiotonic and coronary vasodilatatory effects of amrinone in the canine heart-lung preparation with a support dog as compared with those of dobutamine.
    Takeda K; Matsui K; Nakazawa M; Nakahara H; Imai H; Imai S
    Jpn J Pharmacol; 1986 Mar; 40(3):381-8. PubMed ID: 3012165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac effects of amrinone on rabbit papillary muscle and guinea pig Langendorff heart preparations.
    Onuaguluchi G; Tanz RD
    J Cardiovasc Pharmacol; 1981; 3(6):1342-55. PubMed ID: 6173535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
    Hashimoto K; Yabuuchi Y; Yamashita S; Mori T
    Arzneimittelforschung; 1984; 34(3A):390-3. PubMed ID: 6540094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration-response curves of positive inotropic agents before and after ouabain pretreatment.
    Brown L; Erdmann E
    Cardiovasc Res; 1985 May; 19(5):288-98. PubMed ID: 3995524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of OPC-18790, amrinone and dobutamine on cardiac function and energy metabolism in the guinea-pig isolated ischaemic heart.
    Itoh S; Mori T; Tominaga M; Ishikawa M; Koga K; Yabuuchi Y
    Br J Pharmacol; 1995 Mar; 114(5):1090-6. PubMed ID: 7780644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle.
    Binah O; Sodowick B; Vulliemoz Y; Danilo P; Rosen M
    Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial pharmacodynamics of dopamine, dobutamine, amrinone and isoprenaline compared in the isolated rabbit heart.
    Vigholt Sørensen E; Nielsen-Kudsk F
    Eur J Pharmacol; 1986 May; 124(1-2):51-7. PubMed ID: 3720844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of the bipyridines: amrinone and milrinone.
    Alousi AA; Johnson DC
    Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses to amrinone in isolated cardiac muscles from cat, rabbit, and guinea pig.
    Siegl PK; Morgan G; Sweet CS
    J Cardiovasc Pharmacol; 1984; 6(2):281-7. PubMed ID: 6200717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
    Endoh M; Yanagisawa T; Taira N; Blinks JR
    Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental changes in the interactions of amrinone and ouabain in canine ventricular muscle.
    Binah O; Rosen MR
    Dev Pharmacol Ther; 1983; 6(5):333-46. PubMed ID: 6628165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of intravenous amrinone: the first of a new class of positive inotropic agents with vasodilator properties.
    Bottorff MB; Rutledge DR; Pieper JA
    Pharmacotherapy; 1985; 5(5):227-37. PubMed ID: 3906583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine.
    Shen W; Gill RM; Jones BD; Zhang JP; Corbly AK; Steinberg MI
    J Pharmacol Exp Ther; 2002 Nov; 303(2):673-80. PubMed ID: 12388650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and adenylate cyclase stimulating effects of colforsin daropate, a water-soluble forskolin derivative, compared with those of isoproterenol, dopamine and dobutamine.
    Yoneyama M; Sugiyama A; Satoh Y; Takahara A; Nakamura Y; Hashimoto K
    Circ J; 2002 Dec; 66(12):1150-4. PubMed ID: 12499623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one].
    Alousi AA; Farah AE; Lesher GY; Opalka CJ
    Circ Res; 1979 Nov; 45(5):666-77. PubMed ID: 39684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct vasodilator and positive inotropic actions of amrinone.
    Millard RW; Dubé G; Grupp G; Grupp I; Alousi A; Schwartz A
    J Mol Cell Cardiol; 1980 Jun; 12(6):647-52. PubMed ID: 7452740
    [No Abstract]   [Full Text] [Related]  

  • 18. Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle.
    Endoh M; Yamashita S; Taira N
    J Pharmacol Exp Ther; 1982 Jun; 221(3):775-83. PubMed ID: 6283063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inotropic and vasodilator effects of amrinone on isolated human tissue.
    Wilmshurst PT; Walker JM; Fry CH; Mounsey JP; Twort CH; Williams BT; Davies MJ; Webb-Peploe MM
    Cardiovasc Res; 1984 May; 18(5):302-9. PubMed ID: 6733734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the cardiotonic effects of milrinone, a new and potent cardiac bipyridine, on isolated tissues from several animal species.
    Alousi AA; Stankus GP; Stuart JC; Walton LH
    J Cardiovasc Pharmacol; 1983; 5(5):804-11. PubMed ID: 6195468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.